Who
Brian Grow
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Organogenesis Holdings.
In numbers
- Trades disclosed
- 70
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Dec 2018
- Last trade
- 18 Feb 2026
- Last filed
- 24 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,818 at $0.00 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $46K11,887 at $3.84 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,818 at $0.00 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $46K11,887 at $3.84 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —234,375 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,330 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $45K11,768 at $3.84 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —133,630 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —133,630 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —234,375 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,330 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $45K11,768 at $3.84 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $12K3,346 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $71K18,910 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $39K10,559 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $42K11,144 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $12K3,346 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $71K18,910 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $39K10,559 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $42K11,144 at $3.73 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.